Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control.

BACKGROUND Oral cleansing with chlorhexidine decreases the incidence of nosocomial pneumonia in patients after cardiac surgery. However, evidence of its benefit in ICU patients is conflicting. METHODS Patients admitted to the ICU of an Indian tertiary care teaching hospital were randomized to twice-daily oropharyngeal cleansing with 0.2% chlorhexidine or 0.01% potassium permanganate (control) solution. Effects on the incidence of nosocomial pneumonia during ICU stay (primary outcome) and length of ICU stay and in-hospital mortality (secondary outcomes) were studied. RESULTS Five hundred twelve patients were randomized to either the chlorhexidine group (n = 250) or the control group (n = 262). Of the 471 subjects who completed the protocol, nosocomial pneumonia developed in 16 of 224 subjects (7.1%) in the chlorhexidine group and 19 of 247 subjects (7.7%) in the control group (p = 0.82; relative risk, 0.93; 95% confidence interval, 0.49 to 1.76); intention-to-treat analysis of 21 patients in whom the cleansing protocol was not followed revealed similar results. There was no significant difference between the study and control groups in the median day of development of pneumonia (5.0 days: interquartile range [IQR], 3.0 to 7.7 vs 5.0 days: IQR, 3.0 to 6.0, respectively), median ICU stay (5.0 days: IQR, 3.0 to 8.0 vs 6.0 days: IQR, 3.0 to 8.0, respectively), and mortality (34.8% vs 28.3%, respectively). On subgroup analysis, there was no significant difference in the primary and secondary outcomes in patients on mechanical ventilation, tracheal intubation, and coma (Glasgow coma scale <or= 8). During the study period, nosocomial pneumonia developed in fewer subjects (35 of 471 subjects [7.4%]) than in the 3 months preceding and following the study (98 of 452 subjects [21.7%]; p < 0.001; relative risk, 0.34; 95% confidence interval, 0.24 to 0.49). CONCLUSIONS Oropharyngeal cleansing with 0.2% chlorhexidine solution was not superior to oral cleansing with the control solution. However, the decreased incidence of nosocomial pneumonia during the study period suggests a possible benefit of meticulous oral hygiene in ICU patients.

[1]  P. Kam,et al.  Chlorhexidine - Pharmacology and Clinical Applications , 2008, Anaesthesia and intensive care.

[2]  V. Thamlikitkul,et al.  Randomized Controlled Trial and Meta-analysis of Oral Decontamination with 2% Chlorhexidine Solution for the Prevention of Ventilator-Associated Pneumonia , 2008, Infection Control &#x0026; Hospital Epidemiology.

[3]  J. Decruyenaere,et al.  Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. , 2007, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[4]  G. Şenol,et al.  In vitro antibacterial activities of oral care products against ventilator-associated pneumonia pathogens. , 2007, American journal of infection control.

[5]  N. Safdar,et al.  Topical chlorhexidine for prevention of ventilator-associated pneumonia: A meta-analysis* , 2007, Critical care medicine.

[6]  B. D. de Mol,et al.  Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. , 2006, JAMA.

[7]  F. Scannapieco,et al.  Pneumonia in nonambulatory patients. The role of oral bacteria and oral hygiene. , 2006, Journal of the American Dental Association.

[8]  M. Bonten,et al.  Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. , 2006, American journal of respiratory and critical care medicine.

[9]  M. Kollef.  Ventilator-Associated Pneumonia , 2005 .

[10]  C. di Pompéo,et al.  Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: A double-blind placebo-controlled multicenter study* , 2005, Critical care medicine.

[11]  A. El‐Solh,et al.  Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. , 2004, Chest.

[12]  D. Cook,et al.  Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia , 2004, Annals of Internal Medicine.

[13]  S. Socransky,et al.  The effect of a chlorhexidine regimen on de novo plaque formation. , 2004, Journal of clinical periodontology.

[14]  K. Ward,et al.  Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. , 2004, Heart & lung : the journal of critical care.

[15]  J. Vincent.  Nosocomial infections in adult intensive-care units , 2003, The Lancet.

[16]  M. Larocco,et al.  Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. , 2002, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[17]  C. Chopin,et al.  Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients , 2000, Intensive Care Medicine.

[18]  G. Campbell,et al.  Blinded invasive diagnostic procedures in ventilator-associated pneumonia. , 2000, Chest.

[19]  M. Pittler,et al.  Efficacy and effectiveness , 1999, Focus on Alternative and Complementary Therapies.

[20]  K. Farmer,et al.  Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. , 1999, Clinical therapeutics.

[21]  D. Karnad,et al.  Incidence of nosocomial pneumonia in a medical intensive care unit and general medical ward patients in a public hospital in Bombay, India. , 1998, The Journal of hospital infection.

[22]  A J DeRiso,et al.  Chlorhexidine Gluconate 0.12% Oral Rinse Reduces the Incidence of Total Nosocomial Respiratory Infection and Nonprophylactic Systemic Antibiotic Use in Patients Undergoing Heart Surgery , 1996, Chest.

[23]  J. Faergemann,et al.  The effect of antiseptic solutions on microorganisms in venous leg ulcers. , 1995, Acta dermato-venereologica.

[24]  L K Gottlieb,et al.  Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice? , 1994 .

[25]  A. D. Russell,et al.  Antibacterial activity of chlorhexidine. , 1993, The Journal of hospital infection.

[26]  V. Baselski,et al.  Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions. , 1991, The American review of respiratory disease.

[27]  J. Chastre,et al.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. , 1989, The American review of respiratory disease.

[28]  J. Stalder,et al.  Comparative effects of two topical antiseptics (chlorhexidine vs KMn04) on bacterial skin flora in atopic dermatitis. , 1992, Acta dermato-venereologica. Supplementum.